Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses

Immunogenicity and safety of the fourth dose of quadrivalent human papillomavirus (HPV) vaccine in immunosuppressed women who did not seroconvert after three doses

IntroductionImmunocompromised persons have high risk of persistent human papillomavirus (HPV) infection and HPV-related diseases, and lower immune response to vaccines. This study evaluated the immunogenicity and safety of administering a fourth dose of quadrivalent (4v)HPV vaccine in immunosuppress...

Full description

Saved in:
Bibliographic Details
Main Authors: Lívia Zignago Moreira dos Santos, Camila Cristina Martini Rodrigues, Karina Takesaki Miyaji, Vanessa Infante, Camila de Melo Picone, Amanda Nazareth Lara, Carina Eklund, Hanna Kann, Joakim Dillner, Philippe Mayaud, Ana Marli Christovam Sartori
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
immunogenicity
vaccine
human papillomavirus (HPV)
kidney transplantation
liver transplantation
heart transplantation
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1451308/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items